Abound Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $979 | Hold |
3
| – | – | ﹤0.01% | 805 |
|
|
2025
Q1 | $811 | Sell |
3
-1
| -25% | -$270 | ﹤0.01% | 774 |
|
|
2024
Q4 | $885 | Buy |
4
+1
| +33% | +$221 | ﹤0.01% | 749 |
|
|
2024
Q3 | $826 | Buy |
+3
| New | +$826 | ﹤0.01% | 799 |
|
|
2024
Q2 | – | Sell |
-3
| Closed | -$449 | – | 1175 |
|
|
2024
Q1 | $449 | Sell |
3
-1
| -25% | -$150 | ﹤0.01% | 928 |
|
|
2023
Q4 | $706 | Buy |
4
+1
| +33% | +$177 | ﹤0.01% | 845 |
|
|
2023
Q3 | $532 | Hold |
3
| – | – | ﹤0.01% | 796 |
|
|
2023
Q2 | $570 | Buy |
+3
| New | +$570 | ﹤0.01% | 807 |
|